Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Crossover Study of the Safety, Efficacy and Pharmacokinetics of Two Escalating, Oral Doses of V3381 (200 mg BID and 400 mg BID) for 28 Days in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)
NCT00375960 is registered in ClinicalTrials.gov with Vernalis (R&D) Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Crossover Study of the Safety, Efficacy and Pharmacokinetics of Two Escalating, Oral Doses of V3381 (200 mg BID and 400 mg BID) for 28 Days in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)
- Lead sponsor
- Vernalis (R&D) Ltd
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2006
- Completion date
- April 30, 2007
- Enrollment
- 50
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.